High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy

AIMS: To assess the prognostic importance of high-sensitive C reactive protein (hsCRP) in patients with mild to moderate aortic valve stenosis during placebo or simvastatin/ezetimibe treatment in Simvastatin and Ezetimibe in Aortic Stenosis (SEAS). METHODS AND RESULTS: In 1620 SEAS patients, we meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Blyme, Adam, Asferg, Camilla, Nielsen, Olav W, Sehestedt, Thomas, Kesäniemi, Y Antero, Gohlke-Bärwolf, Christa, Boman, Kurt, Willenheimer, Ronnie, Ray, Simon, Nienaber, Christoph A, Rossebø, Anne, Wachtell, Kristian, Olsen, Michael H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Valvular Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322313/
https://www.ncbi.nlm.nih.gov/pubmed/25685360
http://dx.doi.org/10.1136/openhrt-2014-000152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322313/
https://www.ncbi.nlm.nih.gov/pubmed/25685360
http://dx.doi.org/10.1136/openhrt-2014-000152

Ejemplares similares